Cargando…

Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas

KIR3DL2 is a member of the killer cell immunoglobulin-like receptor (KIR) family that was initially identified at the surface of natural killer (NK) cells. KIR3DL2, also known as CD158k, is expressed as a disulfide-linked homodimer. Each chain is composed of three immunoglobulin-like domains and a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, Christian, Marie-Cardine, Anne, Bensussan, Armand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582066/ https://www.ncbi.nlm.nih.gov/pubmed/28912774 http://dx.doi.org/10.3389/fimmu.2017.01010

Ejemplares similares

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas
por: Marie-Cardine, Anne, et al.
Publicado: (2013)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
por: Giustiniani, Jérôme, et al.
Publicado: (2022)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

KIR2DL4 (CD158d): An activation receptor for HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2012)

Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease
por: Castaño-Núñez, Ángel, et al.
Publicado: (2019)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
por: Zheng, Guoxu, et al.
Publicado: (2022)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression
por: Cisneros, Elisa, et al.
Publicado: (2012)

KIR3DL05 and KIR3DS02 Recognition of a Nonclassical MHC Class I Molecule in the Rhesus Macaque Implicated in Pregnancy Success
por: Nicholas, Rachel E., et al.
Publicado: (2022)

Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression
por: Niu, Chao, et al.
Publicado: (2018)

Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
por: Vargas, Luciana de Brito, et al.
Publicado: (2020)

Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure
por: Woon, Ee Von, et al.
Publicado: (2023)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance
por: Le Luduec, Jean-Benoît, et al.
Publicado: (2019)

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma
por: Decroos, Amandine, et al.
Publicado: (2023)

Stable Frequencies of HLA-C(*)03:04/Peptide-Binding KIR2DL2/3(+) Natural Killer Cells Following Vaccination
por: Ziegler, Maja Christiane, et al.
Publicado: (2018)

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals
por: Zhang, Xin, et al.
Publicado: (2018)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
por: Shaw, Jacqueline, et al.
Publicado: (2012)

Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis
por: Ahn, Richard, et al.
Publicado: (2021)

Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
por: Cassidy, Sorcha, et al.
Publicado: (2014)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
por: Muriuki, Beatrice M., et al.
Publicado: (2023)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
por: Zuo, Wei, et al.
Publicado: (2022)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

Clinical significance and immune landscape of KIR2DL4 and the senescence‐based signature in cutaneous melanoma
por: Mao, Rui, et al.
Publicado: (2022)

Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates
por: Leaton, Laura A., et al.
Publicado: (2019)

A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104
por: van Pul, Lisa, et al.
Publicado: (2020)

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes
por: Falco, Michela, et al.
Publicado: (2022)

Allelic Polymorphism Determines Surface Expression or Intracellular Retention of the Human NK Cell Receptor KIR2DL5A (CD158f)
por: Cisneros, Elisa, et al.
Publicado: (2017)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection
por: Hu, Song, et al.
Publicado: (2022)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_olnpqh73ub0tc5opcnd9f0clnh